Revenue: The sum of all revenue fields included for a company's operating activities.
Enanta Pharmaceuticals, Inc. (ENTA) had Revenue of $67.64M for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$67.64M |
$-116.05M |
|
-- |
|
$67.64M |
|
$189.33M |
|
$-121.69M |
|
$3.90M |
|
$-117.79M |
|
$-117.79M |
|
$-116.05M |
|
$-116.05M |
|
$-116.05M |
|
$-116.05M |
|
$-121.69M |
|
$-120.49M |
|
21.16M |
|
21.16M |
|
$-5.48 |
|
$-5.48 |
|
| Balance Sheet Financials | |
$299.85M |
|
$32.69M |
|
$76.80M |
|
$376.65M |
|
$57.53M |
|
-- |
|
$190.30M |
|
$247.84M |
|
$128.81M |
|
$128.81M |
|
$128.81M |
|
21.19M |
|
| Cash Flow Statement Financials | |
$-78.76M |
|
$58.23M |
|
$-27.63M |
|
$89.36M |
|
$41.20M |
|
$-48.16M |
|
$26.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-179.92% |
|
-179.92% |
|
-178.15% |
|
-174.15% |
|
-171.58% |
|
$-96.71M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
1.75 |
|
208.55 |
|
-90.09% |
|
-90.09% |
|
-30.81% |
|
-90.09% |
|
$6.08 |
|
$-4.57 |
|
$-3.72 |
|